These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9857340)

  • 1. A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma.
    Zemann BI; Moore AS; Rand WM; Mason G; Ruslander DM; Frimberger AE; Wood CA; L'Heureux DA; Gliatto J; Cotter SM
    J Vet Intern Med; 1998; 12(6):465-70. PubMed ID: 9857340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
    Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
    J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma.
    Moore AS; Cotter SM; Rand WM; Wood CA; Williams LE; London CA; Frimberger AE; L'Heureux DA
    J Vet Intern Med; 2001; 15(4):348-54. PubMed ID: 11467592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and toxicosis of VELCAP-C treatment of lymphoma in cats.
    Hadden AG; Cotter SM; Rand W; Moore AS; Davis RM; Morrissey P
    J Vet Intern Med; 2008; 22(1):153-7. PubMed ID: 18289303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a multidrug chemotherapy protocol (ACOPA II) in dogs with lymphoma.
    Myers NC; Moore AS; Rand WM; Gliatto J; Cotter SM
    J Vet Intern Med; 1997; 11(6):333-9. PubMed ID: 9470157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of canine lymphoma with COPLA/LVP.
    Boyce KL; Kitchell BE
    J Am Anim Hosp Assoc; 2000; 36(5):395-403. PubMed ID: 10997514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol.
    Simon D; Nolte I; Eberle N; Abbrederis N; Killich M; Hirschberger J
    J Vet Intern Med; 2006; 20(4):948-54. PubMed ID: 16955821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thirteen-week dose-intensifying simultaneous combination chemotherapy protocol for malignant lymphoma in dogs.
    Zenker I; Meichner K; Steinle K; Kessler M; Hirschberger J
    Vet Rec; 2010 Nov; 167(19):744-8. PubMed ID: 21257510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007).
    Flory AB; Rassnick KM; Erb HN; Garrett LD; Northrup NC; Selting KA; Phillips BS; Locke JE; Chretin JD
    J Am Vet Med Assoc; 2011 Feb; 238(4):501-6. PubMed ID: 21320021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma.
    Daters AT; Mauldin GE; Mauldin GN; Brodsky EM; Post GS
    Vet Comp Oncol; 2010 Mar; 8(1):11-22. PubMed ID: 20230577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome and toxicity associated with a dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 cases.
    Sorenmo K; Overley B; Krick E; Ferrara T; LaBlanc A; Shofer F
    Vet Comp Oncol; 2010 Sep; 8(3):196-208. PubMed ID: 20691027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy versus chemotherapy with intralymphatic tumor cell vaccine in canine lymphoma.
    Jeglum KA; Young KM; Barnsley K; Whereat A
    Cancer; 1988 May; 61(10):2042-50. PubMed ID: 3359402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of COAP and UW-19 protocols for dogs with multicentric lymphoma.
    Hosoya K; Kisseberth WC; Lord LK; Alvarez FJ; Lara-Garcia A; Kosarek CE; London CA; Couto CG
    J Vet Intern Med; 2007; 21(6):1355-63. PubMed ID: 18196747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of L-asparaginase: polyethylene glycol conjugate versus native L-asparaginase combined with chemotherapy. A randomized double-blind study in canine lymphoma.
    MacEwen EG; Rosenthal RC; Fox LE; Loar AS; Kurzman ID
    J Vet Intern Med; 1992; 6(4):230-4. PubMed ID: 1522554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is maintenance chemotherapy appropriate for the management of canine malignant lymphoma?
    Hahn KA; Richardson RC; Teclaw RF; Cline JM; Carlton WW; DeNicola DB; Bonney PL
    J Vet Intern Med; 1992; 6(1):3-10. PubMed ID: 1548624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II clinical trial of combination chemotherapy with dexamethasone for lymphoma in dogs.
    Greenberg CB; Boria PA; Borgatti-Jeffreys A; Raskin RE; Lucroy MD
    J Am Anim Hosp Assoc; 2007; 43(1):27-32. PubMed ID: 17209082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of asparaginase administered subcutaneously versus intramuscularly for treatment of multicentric lymphoma in dogs receiving doxorubicin.
    Valerius KD; Ogilvie GK; Fettman MJ; Walton JA; Richardson K; Powers BE; McNiel EA; Rogers QR
    J Am Vet Med Assoc; 1999 Feb; 214(3):353-6. PubMed ID: 10023395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a continuous, multiagent chemotherapeutic protocol versus a short-term single-agent protocol in dogs with lymphoma.
    Simon D; Moreno SN; Hirschberger J; Moritz A; Kohn B; Neumann S; Jurina K; Scharvogel S; Schwedes C; Reinacher M; Beyerbach M; Nolte I
    J Am Vet Med Assoc; 2008 Mar; 232(6):879-85. PubMed ID: 18341445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy with continuous L-asparaginase, lomustine, and prednisone for relapsed canine lymphoma.
    Saba CF; Hafeman SD; Vail DM; Thamm DH
    J Vet Intern Med; 2009; 23(5):1058-63. PubMed ID: 19678892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential low-dose rate half-body irradiation and chemotherapy for the treatment of canine multicentric lymphoma.
    Lurie DM; Gordon IK; Théon AP; Rodriguez CO; Suter SE; Kent MS
    J Vet Intern Med; 2009; 23(5):1064-70. PubMed ID: 19627472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.